Wilms Tumor: Gaurav Nahar DNB Urology (STD) MMHRC, Madurai
Wilms Tumor: Gaurav Nahar DNB Urology (STD) MMHRC, Madurai
Wilms Tumor: Gaurav Nahar DNB Urology (STD) MMHRC, Madurai
Gaurav Nahar
DNB Urology(Std)
MMHRC, Madurai
INTRODUCTION
Wilms tumor - Nephroblastoma.
Most common primary malignant renal tumor
of childhood.
This embryonal tumor develops from remnants
of immature kidney.
EPIDEMIOLOGY
Accounts for 6% to 7% of all childhood
cancers.
Children<15 yrs: annual incidence rate 7 to 10
cases per million.
More than 80% of cases are diagnosed before
5 years of age, with a median age of 3.5 years.
ETIOLOGY
Majority of Wilms tumors arise from somatic
mutations restricted to tumor tissue.
A much smaller percentage originate from
germline mutations.
Several genetic events result in Wilms tumor
development.
WT1:
1st Wilms tumor gene to be identified.
Gross deletions at chromosome 11p13.
Associated syndromes:
1.WAGR syndrome
2.Denys-Drash syndrome
3.Frasier syndrome
WT2:
11p15 locus- LoH(Loss of Heterozygosity)
a/w Beckwith-Wiedemann Syndrome.
Genes involved- H19 & IGF-2.
Beckwith-Wiedemann syndrome(BWS)
characterized by excess growth at cellular,
organ (macroglossia, nephromegaly,
hepatomegaly), or body segment
(hemihypertrophy) levels.
Adrenocortical neoplasms and hepatoblastoma
also occur in BWS.
Most cases sporadic; 15% heritable- AD.
WTX:
Tumor suppressor gene, Wilms Tumor gene on
the X chromosome, at Xq11.1,
Inactivated in up to one third of Wilm's
tumors.
Targets single X chromosome in males &
active X chromosome in females with tumors.
SCREENING
Ultrasound surveillance- from time of
diagnosis until 5 years of age, with a
frequency of every 3 to 4 months.
BWS, Simpson-Golabi-Behmel, and familial
Wilms- continue to 7 years.
Screening recommended when WT incidence
> 5%.
Screening of contralateral kidney after
nephrectomy for U/L Wilm's.
PATHOLOGY
Favorable-Histology Wilms Tumor(FH):
Wilms tumor compresses adjacent normal
renal parenchyma, forming an "intrarenal
pseudocapsule."
Tremendous histologic diversity.
90% of all renal tumors have favorable
histology.
Resistant to chemotherapy.
Poor prognosis.
Further divided into focal & diffuse patterns.
Nephrogenis Rests:
Precursor lesions; still most don't form Wilm's
tumor.
A rest can undergo maturation, sclerosis,
involution, or complete disappearance.
Two types based on location: Perilobar &
Intralobar(PLNRs & ILNRs).
CLINICAL PRESENTATION
A palpable smooth abdominal mass- 90%.
Incidentally discovered.
Abdominal pain, gross hematuria & fever- less
frequent.
Tumor rupture with hemorrhage into peritoneal
cavity- mimics acute abdomen.
Extension into renal vein & IVC- varicocoele,
hepatomegaly due to hepatic vein obstruction, ascites,
and congestive heart failure- <10%.
IMAGING
FOUR FIELD CHEST RADIOGRAPHY:
may show lung metastasis.
RENAL ULTRASOUND:
1st study to evaluate child with abd.mass.
demonstrate solid nature of the lesion.
Doppler USG helps to exclude intracaval
tumor extension, & its proximal extent.
CT SCAN:
helps to determine origin of the tumor, lymph
node involvement, B/L kidney involvement,
invasion into major vessels (IVC), and liver
metastases.
CT chest to rule out lung metastasis.
MRI ABDOMEN:
Most sensitive imaging modality for caval
patency, to determine tumor extension into
IVC.
low signal intensity on T1-weighted images
and high signal intensity on T2-weighted
images.
STAGING
DIFFERENTIAL DIAGNOSIS
Differential Diagnoses
Neuroblastoma
Polycystic Kidney Disease
Rhabdomyosarcoma
PROGNOSTIC FACTORS
Most Important determinants of outcome:
histopathology & tumor stage.
Chromosomal Abnormalities: LOH for
chromosome 16q and/or 1p (20% of Wilms
tumors) a/w increased risk for relapse & death.
High telomerase activity- an unfavourable
prognostic feature.
DNA Content: Aneuploidy & DNA index . 1.5strongly a/w anaplastic histology.
Cytokines: VEGF angiogenic cytokine.
TREAMENT
Usual approach- nephrectomy followed by
chemotherapy, with or without postoperative
radiotherapy.
Multiple RCTs to determine therapeutic protocols by:
1. National Wilm's Tumor Study Group/Children's
Oncology Group(NWTSG/COG),
2. International Society of Pediatric Oncology(SIOP),
and
3. United Kingdom Childrens Cancer Study Group
(UKCCSG) .
SURGICAL CONSIDERATIONS:
Radical nephrectomy by transperitoneal approach.
Thorough exploration of the abdominal cavity to
exclude local tumor extension, liver and nodal
metastases, or peritoneal seeding.
Accurate staging to determine appropriate
chemotherapy & need for radiation therapy.
Selective sampling of suspicious nodes is essential.
Formal RPLND is not recommended.
PREOPERATIVE CHEMOTHERAPY:
Situations where preoperative chemotherapy is
recommended:1. Children for whom renal-sparing surgery is planned,
2. Tumors are inoperable at surgical exploration, and
3. There is tumor extension into IVC above hepatic
veins.
An inoperable tumor should be considered stage III
and treated accordingly.
LATE EFFECTS OF Rx
RADIATION:
Musculoskeletal problems like scoliosis.
Reduction in stature.
Hypogonadism & temporary azoospermia.
Delayed sexual maturation.
Ovarian failure.
Adverse pregnancy outcomes with increased
risk for miscarriage, LBW, prematurity &
congenital malformations.
Increased risk of 2nd malignant neoplasms.
CHEMO:
Congestive heart failure caused by
anthracyclines(DOX)
FOLLOW-UP
THANK
YOU